Use of anti-il-12 antibodies in transplantation rejection

Details Use of anti-il-12 antibodies in transplantation rejection Use of anti-il-12 antibodies in transplantation rejection

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 38/13 (2006.01) C07K 16/24 (2006.01)

Patent

CA 2276420

Methods are disclosed for reducing or ameliorating chronic rejection of a transplanted tissue by administration of an anti-IL-12 antibody, alone or in combination with other beneficial therapeutic agents.

On décrit des procédés permettant de réduire ou d'améliorer le rejet chronique d'un tissu transplanté au moyen de l'administration d'un anticorps anti-IL 12, administré seul ou en combinaison avec d'autres agents thérapeutiques bénéfiques.

Affiliated with

Also associated with

Rating

Use of anti-il-12 antibodies in transplantation rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of anti-il-12 antibodies in transplantation rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of anti-il-12 antibodies in transplantation rejection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1388409